Beam Therapeutics Inc.
BEAM
Revenue
11.77M
▲4.36M▲58.87%
3 Months ChangeAssets
1.26B
▼-98.53M▼-7.25%
3 Months ChangeLiabilities
407.17M
▼-39.13M▼-8.77%
3 Months ChangeFree Cash Flow
-102.19M
▲13.65M▲11.78%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-06
Form 10-Q
ID: 0000950170-24-091242
2024-08-06
Form 8-K
ID: 0000950170-24-091201
2024-07-15
Form 8-K
ID: 0001193125-24-178824
2024-06-10
Form 8-K
ID: 0000950170-24-071345
2024-05-07
Form 10-Q
ID: 0000950170-24-053939
2024-05-07
Form 8-K
ID: 0000950170-24-053928
2024-02-27
Form 8-K
ID: 0000950170-24-020608
2024-01-08
Form 8-K
ID: 0000950170-24-002673
2023-12-14
Form 8-K
ID: 0001193125-23-295457
2023-11-08
Form 10-Q
ID: 0000950170-23-060683